StockIQpro
NASDAQ:RXST

RxSight, Inc.

Track all markets on TradingView
Track all markets on TradingView

RxSight, Inc.'s revenue fell 3.9% in fiscal 2025 to $134.5M while operating margin fell to −35.8%. Free cash flow was −$19.3M, −14.4% of revenue, and the diluted share count rose 5.1%.Summary generated from RxSight, Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$134.5M
Revenue growth−3.9%
Revenue, 5-yr CAGR+55.7%
Gross margin76.6%
Operating margin−35.8%
Net margin−29.0%
ROICn/a
Return on equity−14.0%
Debt / equityn/a
Free cash flow−$19.3M
FCF margin−14.4%
Share count change+5.1%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue234989140134
Operating income−53−63−50−37−48
Net income−49−67−49−27−39
Free cash flow−47−61−46−22−19

Recent filings

From SEC EDGAR

Peers

Ophthalmic goods